Long‐term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies
Identifieur interne : 000166 ( France/Analysis ); précédent : 000165; suivant : 000167Long‐term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies
Auteurs : Peggy Reiner [France] ; Damien Galanaud [France] ; Gaëlle Leroux [France] ; Marie Vidailhet [France] ; Julien Haroche [France] ; Du Le Thi Huong [France] ; Camille Francès [France] ; Thomas Papo [France] ; Christian De Gennes [France] ; Lucile Musset [France] ; Bertrand Wechsler [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Nathalie Costedoat-Chalumeau [France]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-11.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Adolescent, Adult, Antibodies, Antiphospholipid (biosynthesis), Antiphospholipid Syndrome (complications), Antiphospholipid Syndrome (immunology), Antiphospholipid Syndrome (physiopathology), Antiphospholipid antibody syndrome, Antipsychotic Agents (therapeutic use), Arteries (physiopathology), Child, Chorea, Chorea (drug therapy), Chorea (immunology), Chorea (physiopathology), Female, Follow-Up Studies, Human, Humans, Long term, Lupus Erythematosus, Systemic (immunology), Lupus Erythematosus, Systemic (physiopathology), Male, Middle Aged, Nervous system diseases, Platelet, Prognosis, Retrospective Studies, Risk, Steroids (therapeutic use), Systemic lupus erythematosus, Thrombosis, Thrombosis (immunology), Thrombosis (physiopathology), Time Factors, Treatment Outcome, Young Adult, antiphospholipid, chorea, lupus, thrombosis.
- MESH :
- chemical , biosynthesis : Antibodies, Antiphospholipid.
- complications : Antiphospholipid Syndrome.
- drug therapy : Chorea.
- immunology : Antiphospholipid Syndrome, Chorea, Lupus Erythematosus, Systemic, Thrombosis.
- physiopathology : Antiphospholipid Syndrome, Arteries, Chorea, Lupus Erythematosus, Systemic, Thrombosis.
- chemical , therapeutic use : Antipsychotic Agents, Steroids.
- mix :
Abstract
Objective:: The aim of this work was to describe chorea during systemic lupus erythematosus or antiphospholipid antibodies and its long‐term outcome. Methods:: We retrospectively analyzed clinical features, laboratory findings, imaging characteristics, and outcome in a series of 32 patients. Results:: Most patients were women (28 of 32), and mean age at onset of chorea was 20.6 (9–62) years. Chorea was inaugural for 28 patients. Improvement was observed with various treatments. During follow‐up (12.2 ± 11.3 years), severe manifestations of systemic lupus erythematosus were rare. Antiphospholipid antibodies were repeatedly positive for 90% of the patients. Twelve patients developed arterial thrombosis. Prophylactic treatment with antithrombotic therapy might reduce the risk of further thrombosis (8% versus 57%; P = 0.01). Cardiac valvulopathy occurred in 22 patients during follow‐up. Chorea relapsed in 8 cases. Conclusions:: Chorea had a good outcome in itself. This long‐term follow‐up shows, for the first time, that these patients have substantial risk for further arterial thrombosis. © 2011 Movement Disorder Society
Url:
- https://api.istex.fr/document/D4F441530FB5E899F88F218D9988BAF91B915591/fulltext/pdf
- https://hal.inria.fr/hal-00795754
DOI: 10.1002/mds.23863
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000B46
- to stream Istex, to step Curation: 000B46
- to stream Istex, to step Checkpoint: 000310
- to stream Hal, to step Corpus: 000040
- to stream Hal, to step Curation: 000040
- to stream Hal, to step Checkpoint: 000016
- to stream PubMed, to step Corpus: 001081
- to stream PubMed, to step Curation: 001081
- to stream PubMed, to step Checkpoint: 001260
- to stream Ncbi, to step Merge: 003349
- to stream Ncbi, to step Curation: 003349
- to stream Ncbi, to step Checkpoint: 003349
- to stream Main, to step Merge: 001631
- to stream PascalFrancis, to step Corpus: 000339
- to stream PascalFrancis, to step Curation: 002975
- to stream PascalFrancis, to step Checkpoint: 000532
- to stream Main, to step Merge: 001B22
- to stream Main, to step Curation: 001578
- to stream Main, to step Exploration: 001578
- to stream France, to step Extraction: 000166
Links to Exploration step
ISTEX:D4F441530FB5E899F88F218D9988BAF91B915591Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long‐term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies</title>
<author><name sortKey="Reiner, Peggy" sort="Reiner, Peggy" uniqKey="Reiner P" first="Peggy" last="Reiner">Peggy Reiner</name>
</author>
<author><name sortKey="Galanaud, Damien" sort="Galanaud, Damien" uniqKey="Galanaud D" first="Damien" last="Galanaud">Damien Galanaud</name>
</author>
<author><name sortKey="Leroux, Gaelle" sort="Leroux, Gaelle" uniqKey="Leroux G" first="Gaëlle" last="Leroux">Gaëlle Leroux</name>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
</author>
<author><name sortKey="Haroche, Julien" sort="Haroche, Julien" uniqKey="Haroche J" first="Julien" last="Haroche">Julien Haroche</name>
</author>
<author><name sortKey="Huong, Du Le Thi" sort="Huong, Du Le Thi" uniqKey="Huong D" first="Du Le Thi" last="Huong">Du Le Thi Huong</name>
</author>
<author><name sortKey="Frances, Camille" sort="Frances, Camille" uniqKey="Frances C" first="Camille" last="Francès">Camille Francès</name>
</author>
<author><name sortKey="Papo, Thomas" sort="Papo, Thomas" uniqKey="Papo T" first="Thomas" last="Papo">Thomas Papo</name>
</author>
<author><name sortKey="De Gennes, Christian" sort="De Gennes, Christian" uniqKey="De Gennes C" first="Christian" last="De Gennes">Christian De Gennes</name>
</author>
<author><name sortKey="Musset, Lucile" sort="Musset, Lucile" uniqKey="Musset L" first="Lucile" last="Musset">Lucile Musset</name>
</author>
<author><name sortKey="Wechsler, Bertrand" sort="Wechsler, Bertrand" uniqKey="Wechsler B" first="Bertrand" last="Wechsler">Bertrand Wechsler</name>
</author>
<author><name sortKey="Amoura, Zahir" sort="Amoura, Zahir" uniqKey="Amoura Z" first="Zahir" last="Amoura">Zahir Amoura</name>
</author>
<author><name sortKey="Piette, Jean Harles" sort="Piette, Jean Harles" uniqKey="Piette J" first="Jean-Charles" last="Piette">Jean-Charles Piette</name>
</author>
<author><name sortKey="Costedoat Halumeau, Nathalie" sort="Costedoat Halumeau, Nathalie" uniqKey="Costedoat Halumeau N" first="Nathalie" last="Costedoat-Chalumeau">Nathalie Costedoat-Chalumeau</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D4F441530FB5E899F88F218D9988BAF91B915591</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1002/mds.23863</idno>
<idno type="url">https://api.istex.fr/document/D4F441530FB5E899F88F218D9988BAF91B915591/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000B46</idno>
<idno type="wicri:Area/Istex/Curation">000B46</idno>
<idno type="wicri:Area/Istex/Checkpoint">000310</idno>
<idno type="wicri:doubleKey">0885-3185:2011:Reiner P:long:term:outcome</idno>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-00795754</idno>
<idno type="url">https://hal.inria.fr/hal-00795754</idno>
<idno type="wicri:Area/Hal/Corpus">000040</idno>
<idno type="wicri:Area/Hal/Curation">000040</idno>
<idno type="wicri:Area/Hal/Checkpoint">000016</idno>
<idno type="wicri:doubleKey">0885-3185:2011:Reiner P:long:term:outcome</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:21755538</idno>
<idno type="wicri:Area/PubMed/Corpus">001081</idno>
<idno type="wicri:Area/PubMed/Curation">001081</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001260</idno>
<idno type="wicri:Area/Ncbi/Merge">003349</idno>
<idno type="wicri:Area/Ncbi/Curation">003349</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003349</idno>
<idno type="wicri:Area/Main/Merge">001631</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:12-0026980</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000339</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002975</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000532</idno>
<idno type="wicri:doubleKey">0885-3185:2011:Reiner P:long:term:outcome</idno>
<idno type="wicri:Area/Main/Merge">001B22</idno>
<idno type="wicri:Area/Main/Curation">001578</idno>
<idno type="wicri:Area/Main/Exploration">001578</idno>
<idno type="wicri:Area/France/Extraction">000166</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Long‐term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies</title>
<author><name sortKey="Reiner, Peggy" sort="Reiner, Peggy" uniqKey="Reiner P" first="Peggy" last="Reiner">Peggy Reiner</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie, AP‐HP, Hôpital Lariboisière, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Galanaud, Damien" sort="Galanaud, Damien" uniqKey="Galanaud D" first="Damien" last="Galanaud">Damien Galanaud</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neuroradiologie, AP‐HP, Centre Hospitalier Universitaire Pitié‐Salpêtrière, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Leroux, Gaelle" sort="Leroux, Gaelle" uniqKey="Leroux G" first="Gaëlle" last="Leroux">Gaëlle Leroux</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Médecine Interne, Centre de Référence National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP‐HP, Centre Hospitalier Universitaire Pitié‐Salpêtrière, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Fédération des Maladies du Système Nerveux Central, AP‐HP, Centre Hospitalier Universitaire Pitié‐Salpêtrière, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Haroche, Julien" sort="Haroche, Julien" uniqKey="Haroche J" first="Julien" last="Haroche">Julien Haroche</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Médecine Interne, Centre de Référence National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP‐HP, Centre Hospitalier Universitaire Pitié‐Salpêtrière, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Huong, Du Le Thi" sort="Huong, Du Le Thi" uniqKey="Huong D" first="Du Le Thi" last="Huong">Du Le Thi Huong</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Médecine Interne, Centre de Référence National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP‐HP, Centre Hospitalier Universitaire Pitié‐Salpêtrière, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Frances, Camille" sort="Frances, Camille" uniqKey="Frances C" first="Camille" last="Francès">Camille Francès</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Dermatologie, Hôpital Tenon, AP‐HP, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Papo, Thomas" sort="Papo, Thomas" uniqKey="Papo T" first="Thomas" last="Papo">Thomas Papo</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Médecine Interne, AP‐HP, Hôpital Bichat, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="De Gennes, Christian" sort="De Gennes, Christian" uniqKey="De Gennes C" first="Christian" last="De Gennes">Christian De Gennes</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Médecine Interne, Centre de Référence National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP‐HP, Centre Hospitalier Universitaire Pitié‐Salpêtrière, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Musset, Lucile" sort="Musset, Lucile" uniqKey="Musset L" first="Lucile" last="Musset">Lucile Musset</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service d'Immunochimie, AP‐HP, Centre Hospitalier Universitaire Pitié‐Salpêtrière, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wechsler, Bertrand" sort="Wechsler, Bertrand" uniqKey="Wechsler B" first="Bertrand" last="Wechsler">Bertrand Wechsler</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Médecine Interne, Centre de Référence National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP‐HP, Centre Hospitalier Universitaire Pitié‐Salpêtrière, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Amoura, Zahir" sort="Amoura, Zahir" uniqKey="Amoura Z" first="Zahir" last="Amoura">Zahir Amoura</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Médecine Interne, Centre de Référence National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP‐HP, Centre Hospitalier Universitaire Pitié‐Salpêtrière, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Piette, Jean Harles" sort="Piette, Jean Harles" uniqKey="Piette J" first="Jean-Charles" last="Piette">Jean-Charles Piette</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Médecine Interne, Centre de Référence National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP‐HP, Centre Hospitalier Universitaire Pitié‐Salpêtrière, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Costedoat Halumeau, Nathalie" sort="Costedoat Halumeau, Nathalie" uniqKey="Costedoat Halumeau N" first="Nathalie" last="Costedoat-Chalumeau">Nathalie Costedoat-Chalumeau</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Médecine Interne, Centre de Référence National pour le Lupus Systémique et le Syndrome des Antiphospholipides, AP‐HP, Centre Hospitalier Universitaire Pitié‐Salpêtrière, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-11">2011-11</date>
<biblScope unit="vol">26</biblScope>
<biblScope unit="issue">13</biblScope>
<biblScope unit="page" from="2422">2422</biblScope>
<biblScope unit="page" to="2427">2427</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">D4F441530FB5E899F88F218D9988BAF91B915591</idno>
<idno type="DOI">10.1002/mds.23863</idno>
<idno type="ArticleID">MDS23863</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Antibodies, Antiphospholipid (biosynthesis)</term>
<term>Antiphospholipid Syndrome (complications)</term>
<term>Antiphospholipid Syndrome (immunology)</term>
<term>Antiphospholipid Syndrome (physiopathology)</term>
<term>Antiphospholipid antibody syndrome</term>
<term>Antipsychotic Agents (therapeutic use)</term>
<term>Arteries (physiopathology)</term>
<term>Child</term>
<term>Chorea</term>
<term>Chorea (drug therapy)</term>
<term>Chorea (immunology)</term>
<term>Chorea (physiopathology)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Human</term>
<term>Humans</term>
<term>Long term</term>
<term>Lupus Erythematosus, Systemic (immunology)</term>
<term>Lupus Erythematosus, Systemic (physiopathology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>Platelet</term>
<term>Prognosis</term>
<term>Retrospective Studies</term>
<term>Risk</term>
<term>Steroids (therapeutic use)</term>
<term>Systemic lupus erythematosus</term>
<term>Thrombosis</term>
<term>Thrombosis (immunology)</term>
<term>Thrombosis (physiopathology)</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
<term>antiphospholipid</term>
<term>chorea</term>
<term>lupus</term>
<term>thrombosis</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Antibodies, Antiphospholipid</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Antiphospholipid Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Chorea</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Antiphospholipid Syndrome</term>
<term>Chorea</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Thrombosis</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Antiphospholipid Syndrome</term>
<term>Arteries</term>
<term>Chorea</term>
<term>Lupus Erythematosus, Systemic</term>
<term>Thrombosis</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Steroids</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Homme</term>
<term>Long terme</term>
<term>Lupus érythémateux disséminé</term>
<term>Pathologie du système nerveux</term>
<term>Pronostic</term>
<term>Syndrome choréique</term>
<term>Syndrome des antiphospholipides</term>
<term>Thrombocyte</term>
<term>Thrombose</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
<keywords scheme="mix" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Risk</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
<term>antiphospholipid</term>
<term>chorea</term>
<term>lupus</term>
<term>thrombosis</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Objective:: The aim of this work was to describe chorea during systemic lupus erythematosus or antiphospholipid antibodies and its long‐term outcome. Methods:: We retrospectively analyzed clinical features, laboratory findings, imaging characteristics, and outcome in a series of 32 patients. Results:: Most patients were women (28 of 32), and mean age at onset of chorea was 20.6 (9–62) years. Chorea was inaugural for 28 patients. Improvement was observed with various treatments. During follow‐up (12.2 ± 11.3 years), severe manifestations of systemic lupus erythematosus were rare. Antiphospholipid antibodies were repeatedly positive for 90% of the patients. Twelve patients developed arterial thrombosis. Prophylactic treatment with antithrombotic therapy might reduce the risk of further thrombosis (8% versus 57%; P = 0.01). Cardiac valvulopathy occurred in 22 patients during follow‐up. Chorea relapsed in 8 cases. Conclusions:: Chorea had a good outcome in itself. This long‐term follow‐up shows, for the first time, that these patients have substantial risk for further arterial thrombosis. © 2011 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<settlement><li>Paris</li>
</settlement>
</list>
<tree><country name="France"><noRegion><name sortKey="Reiner, Peggy" sort="Reiner, Peggy" uniqKey="Reiner P" first="Peggy" last="Reiner">Peggy Reiner</name>
</noRegion>
<name sortKey="Amoura, Zahir" sort="Amoura, Zahir" uniqKey="Amoura Z" first="Zahir" last="Amoura">Zahir Amoura</name>
<name sortKey="Costedoat Halumeau, Nathalie" sort="Costedoat Halumeau, Nathalie" uniqKey="Costedoat Halumeau N" first="Nathalie" last="Costedoat-Chalumeau">Nathalie Costedoat-Chalumeau</name>
<name sortKey="De Gennes, Christian" sort="De Gennes, Christian" uniqKey="De Gennes C" first="Christian" last="De Gennes">Christian De Gennes</name>
<name sortKey="Frances, Camille" sort="Frances, Camille" uniqKey="Frances C" first="Camille" last="Francès">Camille Francès</name>
<name sortKey="Galanaud, Damien" sort="Galanaud, Damien" uniqKey="Galanaud D" first="Damien" last="Galanaud">Damien Galanaud</name>
<name sortKey="Haroche, Julien" sort="Haroche, Julien" uniqKey="Haroche J" first="Julien" last="Haroche">Julien Haroche</name>
<name sortKey="Huong, Du Le Thi" sort="Huong, Du Le Thi" uniqKey="Huong D" first="Du Le Thi" last="Huong">Du Le Thi Huong</name>
<name sortKey="Leroux, Gaelle" sort="Leroux, Gaelle" uniqKey="Leroux G" first="Gaëlle" last="Leroux">Gaëlle Leroux</name>
<name sortKey="Musset, Lucile" sort="Musset, Lucile" uniqKey="Musset L" first="Lucile" last="Musset">Lucile Musset</name>
<name sortKey="Papo, Thomas" sort="Papo, Thomas" uniqKey="Papo T" first="Thomas" last="Papo">Thomas Papo</name>
<name sortKey="Piette, Jean Harles" sort="Piette, Jean Harles" uniqKey="Piette J" first="Jean-Charles" last="Piette">Jean-Charles Piette</name>
<name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<name sortKey="Wechsler, Bertrand" sort="Wechsler, Bertrand" uniqKey="Wechsler B" first="Bertrand" last="Wechsler">Bertrand Wechsler</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000166 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000166 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= France |étape= Analysis |type= RBID |clé= ISTEX:D4F441530FB5E899F88F218D9988BAF91B915591 |texte= Long‐term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies }}
This area was generated with Dilib version V0.6.23. |